The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia.
Hematopoietic recovery is considered to be associated with the number of multipotent hematopoietic stem cells in the bone marrow, as observed in functional assays involving stem cell transplantation. However, there is little evidence related to hematopoietic recovery in non-transplantation settings,...
Main Authors: | Runxia Gu, Hui Wei, Ying Wang, Dong Lin, Bingcheng Liu, Chunlin Zhou, Kaiqi Liu, Benfa Gong, Shuning Wei, Guangji Zhang, Xiaoyuan Gong, Yuntao Liu, Yan Li, Xingli Zhao, Shaowei Qiu, Huijun Wang, Min Wang, Yingchang Mi, Jianxiang Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5498054?pdf=render |
Similar Items
-
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia
by: Runxia Gu, et al.
Published: (2020-09-01) -
Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population
by: Hui Wei, et al.
Published: (2018-02-01) -
Childhood acute lymphoblastic leukemia: Immunophenotypic profile and aberrant expression of CD13, CD33, CD117, CD11b, CD16, and CD64
by: Ihsan Mardan Al-Badran, et al.
Published: (2022-01-01) -
Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy
by: Qiang Li, et al.
Published: (2023-03-01) -
The impact of venetoclax based regimens in the preemptive of measurable residual disease in acute myeloid leukemia
by: Qiuyun Fang, et al.
Published: (2022-01-01)